Study finds sharp drop in benzodiazepine use among older adults is drawing significant interest across the industry.
?Benzodiazepine treatment declined among U.S. adults between 2018 and 2022, with the steepest drop among adults ages 56 and older, according to a new study by researchers at the Columbia University Mailman School of Public Health and Columbia University Irving Medical Center.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →